IBIO vs SPG · rev $100.0K vs rev $3.55B
iBio, Inc. Common Stock (IBIO) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
IBIO currently screens at market cap $13.4M. SPG currently screens at market cap $0.
Not investment advice. Open the IBIO and SPG stock pages for the full models.
Not investment advice.